United States · Exchanges & live quotes · Nasdaq
Bristol Myers Squibb's Growth Portfolio Now Brings In $7.7 Billion a Quarter. Here's Why That Changes the Stock's Story.
Detailed summary
Key PointsBristol Myers Squibb is a large and well-respected drug maker.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)
